AI-generated summary
The authors retrospectively compared targeted narrowband UVB, a 308-nm excimer laser, and a 308-nm excimer lamp in vitiligo patients at one clinic. They report no statistically significant difference in repigmentation among the three treatments, but the excimer lamp group had significantly more adverse effects.
- Who or what was studied
- Patients with vitiligo treated at the Photodermatology Clinic, Siriraj Hospital
- Wavelengths
- 308 nm
- Limits stated in the abstract
- The study is retrospective, comparing treatment groups in a single clinic, and the abstract does not state the total number of patients.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on tandfonline.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser, Ultraviolet, Primary outcome. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.